DAXILA is a proton pump inhibitor (PPI) indicated
of all grades of erosive esophagitis (EE).
healing of EE and relief of heartburn.
Treating heartburn associated with symptomatic non-erosive gastroesophageal reflux disease (GERD).
DAXILA (dexlansoprazole) is delayed-release
capsules, a proton pump inhibitor, exhibiting high efficacy
in the treatment of symptoms and lesions associated with erosive
oesophagitis caused by gastroesophageal reflux disease (GERD).
The key to DAXILA's two releases of medicine is its Dual Delayed
Release technology, which combines two different types of
granules in one pill. So DAXILA begins to deliver the first
release of medicine within an hour of taking your pill. Then,
around 4-5 hours later, a second release of medicine arrives.
30 mg & 60 mg Delayed Release Capsules